Cellectar Biosciences Statistics
Total Valuation
CLRB has a market cap or net worth of $97.75 million. The enterprise value is $88.74 million.
| Market Cap | 97.75M |
| Enterprise Value | 88.74M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CLRB has 32.26 million shares outstanding. The number of shares has increased by 73.22% in one year.
| Shares Outstanding | 32.26M |
| Shares Change (YoY) | +73.22% |
| Shares Change (QoQ) | +8.07% |
| Owned by Insiders (%) | 3.57% |
| Owned by Institutions (%) | 30.47% |
| Float | 24.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81
| Current Ratio | 0.81 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -276.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.90M |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -60,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.12% in the last 52 weeks. The beta is 0.94, so CLRB's price volatility has been similar to the market average.
| Beta (1Y) | 0.94 |
| 52-Week Price Change | +96.12% |
| 50-Day Moving Average | 3.66 |
| 200-Day Moving Average | 2.75 |
| Relative Strength Index (RSI) | 34.14 |
| Average Volume (30 Days) | 1,153,711 |
Short Selling Information
The latest short interest is 2.53 million, so 7.85% of the outstanding shares have been sold short.
| Short Interest | 2.53M |
| Short Previous Month | 1.88M |
| Short % of Shares Out | 7.85% |
| Short % of Float | 10.29% |
| Short Ratio (days to cover) | 2.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -38.96M |
| Pretax Income | -38.04M |
| Net Income | -37.98M |
| EBITDA | -37.79M |
| EBIT | -38.04M |
| Earnings Per Share (EPS) | -$3.11 |
Balance Sheet
The company has $9.56 million in cash and $552,982 in debt, giving a net cash position of $9.01 million or $0.28 per share.
| Cash & Cash Equivalents | 9.56M |
| Total Debt | 552,982 |
| Net Cash | 9.01M |
| Net Cash Per Share | $0.28 |
| Equity / Book Value | -1.36M |
| Book Value Per Share | -0.04 |
| Working Capital | -2.48M |
Cash Flow
In the last 12 months, operating cash flow was -$32.38 million and capital expenditures -$864,038, giving a free cash flow of -$33.24 million.
| Operating Cash Flow | -32.38M |
| Capital Expenditures | -864,038 |
| Free Cash Flow | -33.24M |
| FCF Per Share | -$2.72 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CLRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -73.22% |
| Shareholder Yield | -73.22% |
| Earnings Yield | -38.86% |
| FCF Yield | -34.01% |
Analyst Forecast
The average price target for CLRB is $20.00, which is 560.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.00 |
| Price Target Difference | 560.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 22, 2022. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 22, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |